Relationen mellem endometriose og ovariecancer

Ugeskrift for Laeger

Volumn 172, Issue 48, 2010, Pages 3336-3339

  Nyhøj, Lene ^a   Mathiesen, Rikke ^a   Jochumsen, Kirsten Marie ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; OVARY TUMOR; REVIEW; RISK FACTOR;

AGE FACTORS; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 78650647747     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Vercellini P, Parazzini F, Bolis G et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993;169:181-2.
2. Blaakær J, Engelholm SA, Grove A et al. Epitelial ovariecancer (Rekommandationer for diagnostik og behandling i Danmark). www.dgc.eu.com. (1.sep. 2009).
3. Gazvani R, Templeton A. New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet 2002;76:117-26.
4. Rogerio AL. Endometriosis: Etiology, Pathology, Diagnosis, Management. Comprehensive Gynecology. 5. udgave. Udgivelsessted: Philadelphia, PA 19103-2899 Mosby Elsevier, 2007.
5. Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003;189:280-94.
6. Brinton LA, Gridley G, Persson I et al. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-9.
7. Melin A, Sparen P, Persson I et al. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21:1237-42.
8. Jiang X, Hitchcock A, Bryan EJ et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996;56:3534-9.
9. Prefumo F, Todeschini F, Fulcheri E et al. Epithelial abnormalities in cystic ovarian endometriosis. Gynecol Oncol 2002;84:280-4.
10. Clement PB. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol 2007;14:241-60.
11. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990;75:1023-8.
12. Brinton LA, Lamb EJ, Moghissi KS et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004;82:405-14.
13. Hogdall EV, Christensen L, Hogdall CK et al. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas. APMIS 2008;116:400-9.
14. Sainz de la CR, Izquierdo M, Canamero M et al. Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 2004;113:87-93.
15. Jiang X, Morland SJ, Hitchcock A et al. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 199858:1707-12.
16. Goumenou AG, Arvanitis DA, Matalliotakis IM et al. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril 2001;75:160-5.
17. Dinulescu DM, Ince TA, Quade BJ et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005;11:63-70.
18. Wilson TJ, Hertzog PJ, Angus D et al. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994;62:1086-8.
19. Slater M, Cooper M, Murphy CR. Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma. Acta Histochem 2006;108:13-8.